XML 75 R93.htm IDEA: XBRL DOCUMENT v2.4.0.8
Supplemental Condensed Consolidating Financial Statements (Details 3) (USD $)
In Thousands, unless otherwise specified
3 Months Ended 12 Months Ended
Jan. 04, 2014
Sep. 28, 2013
Jun. 29, 2013
Mar. 30, 2013
Dec. 29, 2012
Sep. 29, 2012
Jun. 30, 2012
Mar. 31, 2012
Jan. 04, 2014
Dec. 29, 2012
Dec. 31, 2011
Supplemental Statement Of Stockholders' Equity [Abstract]                      
Balance               $ 8,374 $ (20,592) $ 8,374 $ 991
Net (loss) income (2,457) [1] (3,206) [2] (22,306) [3] (12,649) [4] (11,370) [5] 3,068 [6] (3,706) [7] (11,019) [8] (40,618) (23,027) (38,567)
Foreign currency translation adjustment, net of tax                 (161) 103 (92)
Unrealized (loss) income from pension plan, net of taxes                 13,910 (8,245) (14,969)
Unrealized gain (loss) from cash flow hedge, net of tax                     519
Issuance of restricted stock, net of forfeitures                 6 19 7
Issuance of performance shares                 6    
Issuance of stock related to the rights offerings, net of expenses                 38,613   58,521
Compensation related to share-based grants                 6,117 2,730 2,158
Impact of net settled shares for vested grants                 (3,193) (526) (194)
Excess tax benefits from share-based compensation arrangements                 16    
Other                 (2) (20)  
Net transactions with Parent                         
Balance (5,898)       (20,592)       (5,898) (20,592) 8,374
BlueLinx Holdings Inc.
                     
Supplemental Statement Of Stockholders' Equity [Abstract]                      
Balance               8,374 (20,592) 8,374 991
Net (loss) income                 (40,618) (23,027) (38,567)
Foreign currency translation adjustment, net of tax                 (161) 103 (92)
Unrealized (loss) income from pension plan, net of taxes                 13,910 (8,245) (14,969)
Unrealized gain (loss) from cash flow hedge, net of tax                     519
Issuance of restricted stock, net of forfeitures                 6 19 7
Issuance of performance shares                 6    
Issuance of stock related to the rights offerings, net of expenses                 38,613   58,521
Compensation related to share-based grants                 6,117 2,730 2,158
Impact of net settled shares for vested grants                 (3,193) (526) (194)
Excess tax benefits from share-based compensation arrangements                 16    
Other                 (2) (20)  
Net transactions with Parent                         
Balance (5,898)       (20,592)       (5,898) (20,592) 8,374
BlueLinx Corporation and Subsidiaries
                     
Supplemental Statement Of Stockholders' Equity [Abstract]                      
Balance               83,626 40,603 83,626 94,273
Net (loss) income                 (49,205) (37,237) (52,910)
Foreign currency translation adjustment, net of tax                 (161) 103 (92)
Unrealized (loss) income from pension plan, net of taxes                 13,910 (8,245) (14,969)
Unrealized gain (loss) from cash flow hedge, net of tax                     519
Issuance of restricted stock, net of forfeitures                 6 19   
Issuance of performance shares                 6    
Issuance of stock related to the rights offerings, net of expenses                        
Compensation related to share-based grants                         
Impact of net settled shares for vested grants                         
Other                        
Net transactions with Parent                 43,880 2,337 56,805
Balance 49,039       40,603       49,039 40,603 83,626
LLC Subsidiaries
                     
Supplemental Statement Of Stockholders' Equity [Abstract]                      
Balance               (124,175) (107,656) (124,175) (140,314)
Net (loss) income                 14,343 18,536 18,530
Foreign currency translation adjustment, net of tax                         
Unrealized (loss) income from pension plan, net of taxes                         
Unrealized gain (loss) from cash flow hedge, net of tax                       
Issuance of restricted stock, net of forfeitures                         
Issuance of performance shares                       
Issuance of stock related to the rights offerings, net of expenses                        
Compensation related to share-based grants                         
Impact of net settled shares for vested grants                         
Other                        
Net transactions with Parent                 3,461 (2,017) (2,391)
Balance (96,774)       (107,656)       (96,774) (107,656) (124,175)
Eliminations
                     
Supplemental Statement Of Stockholders' Equity [Abstract]                      
Balance               40,549 67,053 40,549 46,041
Net (loss) income                 34,862 18,701 34,380
Foreign currency translation adjustment, net of tax                 161 (103) 92
Unrealized (loss) income from pension plan, net of taxes                 (13,910) 8,245 14,969
Unrealized gain (loss) from cash flow hedge, net of tax                     (519)
Issuance of restricted stock, net of forfeitures                 (6) (19)   
Issuance of performance shares                 (6)    
Issuance of stock related to the rights offerings, net of expenses                        
Compensation related to share-based grants                         
Impact of net settled shares for vested grants                         
Other                        
Net transactions with Parent                 (40,419) (320) (54,414)
Balance $ 47,735       $ 67,053       $ 47,735 $ 67,053 $ 40,549
[1] During the three months ended January 4, 2014, basic and diluted weighted average shares were 84,818,331, respectively. Total share-based awards of 4,595,650 were excluded from our diluted earnings per share calculation because they were anti-dilutive.
[2] During the three months ended September 28, 2013, basic and diluted weighted average shares were 84,595,708. Total share-based awards of 5,136,430 were excluded from our diluted earnings per share calculation because they were anti-dilutive.
[3] During the three months ended June 29, 2013, basic and diluted weighted average shares were 84,167,120. Total share-based awards of 5,203,076 were excluded from our diluted earnings per share calculation because they were anti-dilutive.
[4] During the three months ended March 30, 2013 basic and diluted weighted average shares were 66,713,964. Total share-based awards of 5,512,899 were excluded from our diluted earnings per share calculation because they were anti-dilutive.
[5] During the three months ended December 29, 2012, basic and diluted weighted average shares were 65,493,920, respectively. Total share-based awards of 4,460,054 were excluded from our diluted earnings per share calculation because they were anti-dilutive.
[6] During the three months ended September 29, 2012, basic and diluted weighted average shares were 65,472,685.
[7] During the three months ended June 30, 2012, basic and diluted weighted average shares were 65,471,450. Total share-based awards of 4,515,590 were excluded from our diluted earnings per share calculation because they were anti-dilutive.
[8] During the three months ended March 31, 2012, basic and diluted weighted average shares were 65,368,259. Total share-based awards of 4,519,590 were excluded from our diluted earnings per share calculation because they were anti-dilutive.